Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

V. J. Hearing, L. W. Law, A. Corti, E. Appella, F. Blasi

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

We have carried out enzymatic, immunofluorescence, and surface iodination studies which show that B16 melanoma cells express the single chain form of the urokinase type plasminogen activator (uPA) on their cell surface, and that these cells are capable of plasminogen-dependent fibronectin degradation. The significance of the expression of surface single-chain uPA and uPA activity to the metastatic process was examined by preincubating melanoma cells with uPA modulating agents followed by i.v. injection of the cells into mice and enumeration of pulmonary nodules 17 days later. B16 cells that had been pretreated with anti-uPA immunoglobulins that were inhibitory to uPA activity invariably showed significantly decreased numbers of metastases compared to controls. On the contrary, pretreatment with plasmin, which is not only the product of the uPA catalyzed reaction but is also able to convert single-chain uPA to uPA, significantly increased the numbers of metastases. Control treatments, which included normal rabbit and mouse immunoglobulins, monovalent noninhibitory anti-uPA Fab fragments, and various monoclonal and polyclonal antibodies directed against other B16 cell surface antigens, did not affect the metastatic potential of the cells. Divalent inhibitory anti-uPA F(ab)2 fragments, on the contrary, inhibited metastasis as efficiently as intact IgG. The results support the hypothesis that proteolysis of extracellular matrix components by cell surface-localized uPA may be a critical step during the process of tumor cell invasion and metastasis.

Original languageEnglish
Pages (from-to)1270-1278
Number of pages9
JournalCancer Research
Volume48
Issue number5
Publication statusPublished - 1988

Fingerprint

Urokinase-Type Plasminogen Activator
Melanoma
Neoplasm Metastasis
Immunoglobulins
Immunoglobulin Fab Fragments
Experimental Melanomas
Plasminogen
Halogenation
Fibrinolysin
Cellular Structures
Surface Antigens
Fibronectins
Proteolysis
Fluorescent Antibody Technique
Extracellular Matrix
Immunoglobulin G
Monoclonal Antibodies
Rabbits

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Hearing, V. J., Law, L. W., Corti, A., Appella, E., & Blasi, F. (1988). Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Research, 48(5), 1270-1278.

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. / Hearing, V. J.; Law, L. W.; Corti, A.; Appella, E.; Blasi, F.

In: Cancer Research, Vol. 48, No. 5, 1988, p. 1270-1278.

Research output: Contribution to journalArticle

Hearing, VJ, Law, LW, Corti, A, Appella, E & Blasi, F 1988, 'Modulation of metastatic potential by cell surface urokinase of murine melanoma cells', Cancer Research, vol. 48, no. 5, pp. 1270-1278.
Hearing, V. J. ; Law, L. W. ; Corti, A. ; Appella, E. ; Blasi, F. / Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. In: Cancer Research. 1988 ; Vol. 48, No. 5. pp. 1270-1278.
@article{a59a3712e0b74236888685749ff64103,
title = "Modulation of metastatic potential by cell surface urokinase of murine melanoma cells",
abstract = "We have carried out enzymatic, immunofluorescence, and surface iodination studies which show that B16 melanoma cells express the single chain form of the urokinase type plasminogen activator (uPA) on their cell surface, and that these cells are capable of plasminogen-dependent fibronectin degradation. The significance of the expression of surface single-chain uPA and uPA activity to the metastatic process was examined by preincubating melanoma cells with uPA modulating agents followed by i.v. injection of the cells into mice and enumeration of pulmonary nodules 17 days later. B16 cells that had been pretreated with anti-uPA immunoglobulins that were inhibitory to uPA activity invariably showed significantly decreased numbers of metastases compared to controls. On the contrary, pretreatment with plasmin, which is not only the product of the uPA catalyzed reaction but is also able to convert single-chain uPA to uPA, significantly increased the numbers of metastases. Control treatments, which included normal rabbit and mouse immunoglobulins, monovalent noninhibitory anti-uPA Fab fragments, and various monoclonal and polyclonal antibodies directed against other B16 cell surface antigens, did not affect the metastatic potential of the cells. Divalent inhibitory anti-uPA F(ab)2 fragments, on the contrary, inhibited metastasis as efficiently as intact IgG. The results support the hypothesis that proteolysis of extracellular matrix components by cell surface-localized uPA may be a critical step during the process of tumor cell invasion and metastasis.",
author = "Hearing, {V. J.} and Law, {L. W.} and A. Corti and E. Appella and F. Blasi",
year = "1988",
language = "English",
volume = "48",
pages = "1270--1278",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "5",

}

TY - JOUR

T1 - Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

AU - Hearing, V. J.

AU - Law, L. W.

AU - Corti, A.

AU - Appella, E.

AU - Blasi, F.

PY - 1988

Y1 - 1988

N2 - We have carried out enzymatic, immunofluorescence, and surface iodination studies which show that B16 melanoma cells express the single chain form of the urokinase type plasminogen activator (uPA) on their cell surface, and that these cells are capable of plasminogen-dependent fibronectin degradation. The significance of the expression of surface single-chain uPA and uPA activity to the metastatic process was examined by preincubating melanoma cells with uPA modulating agents followed by i.v. injection of the cells into mice and enumeration of pulmonary nodules 17 days later. B16 cells that had been pretreated with anti-uPA immunoglobulins that were inhibitory to uPA activity invariably showed significantly decreased numbers of metastases compared to controls. On the contrary, pretreatment with plasmin, which is not only the product of the uPA catalyzed reaction but is also able to convert single-chain uPA to uPA, significantly increased the numbers of metastases. Control treatments, which included normal rabbit and mouse immunoglobulins, monovalent noninhibitory anti-uPA Fab fragments, and various monoclonal and polyclonal antibodies directed against other B16 cell surface antigens, did not affect the metastatic potential of the cells. Divalent inhibitory anti-uPA F(ab)2 fragments, on the contrary, inhibited metastasis as efficiently as intact IgG. The results support the hypothesis that proteolysis of extracellular matrix components by cell surface-localized uPA may be a critical step during the process of tumor cell invasion and metastasis.

AB - We have carried out enzymatic, immunofluorescence, and surface iodination studies which show that B16 melanoma cells express the single chain form of the urokinase type plasminogen activator (uPA) on their cell surface, and that these cells are capable of plasminogen-dependent fibronectin degradation. The significance of the expression of surface single-chain uPA and uPA activity to the metastatic process was examined by preincubating melanoma cells with uPA modulating agents followed by i.v. injection of the cells into mice and enumeration of pulmonary nodules 17 days later. B16 cells that had been pretreated with anti-uPA immunoglobulins that were inhibitory to uPA activity invariably showed significantly decreased numbers of metastases compared to controls. On the contrary, pretreatment with plasmin, which is not only the product of the uPA catalyzed reaction but is also able to convert single-chain uPA to uPA, significantly increased the numbers of metastases. Control treatments, which included normal rabbit and mouse immunoglobulins, monovalent noninhibitory anti-uPA Fab fragments, and various monoclonal and polyclonal antibodies directed against other B16 cell surface antigens, did not affect the metastatic potential of the cells. Divalent inhibitory anti-uPA F(ab)2 fragments, on the contrary, inhibited metastasis as efficiently as intact IgG. The results support the hypothesis that proteolysis of extracellular matrix components by cell surface-localized uPA may be a critical step during the process of tumor cell invasion and metastasis.

UR - http://www.scopus.com/inward/record.url?scp=0023836852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023836852&partnerID=8YFLogxK

M3 - Article

C2 - 2963689

AN - SCOPUS:0023836852

VL - 48

SP - 1270

EP - 1278

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 5

ER -